Suicide prevention in primary care clinics in Nepal
Official title: Integrating a Suicide Prevention Package of Strategies Into Decentralized Primary Health Care Systems: an Implementation Pilot Study in Rural Nepal
Run by Yale University · NCT07362056 · Data updated 2026-11-12
This project will try a package of tools and training to help primary care providers in Bagmati Province, Nepal, better find and manage patients at risk of suicide.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 147 (estimated) |
| Sponsor | Yale University Academic / other |
| Locations | 1 site (Dolakhā) |
| Status | Recruiting |
| Started | November 15, 2025 |
| Main results expected | July 15, 2027 |
| Study ends | August 15, 2027 |
| Registry record updated | January 23, 2026 |
| Trial ID | NCT07362056 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are Nepali-speaking patients who live in the study sites, receive care from a participating primary care provider, and meet any level of suicide risk per mhGAP 2.0 criteria.
✕Probably not a fit
Patients who need immediate hospitalization or who are unable to provide informed consent are excluded and will not directly benefit from this outpatient implementation approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional implementation study will introduce a Suicide Prevention Package (PSuPP) into government primary care facilities and work with providers and patients to integrate mhGAP suicide-risk procedures into routine care. The team will use experience-based co-design with a community advisory board alongside the RE-AIM framework to guide adoption, reach, and sustainability. Participants include licensed primary care providers and patients who speak Nepali and meet mhGAP-defined suicide risk levels; outcomes focus on feasibility, acceptability, and improvements in detection, referral, and follow-up. Yale University, NIMH, and local partners will coordinate implementation in selected sites such as Dolakhā within Bagmati Province.
Why it matters
Potential benefit: If successful, the package could increase identification, referral, and follow-up of people at suicide risk in primary care and reduce suicide-related harm in participating communities.
How similar studies have gone: Related mhGAP-based task-sharing and implementation efforts in low-resource settings have shown promise for improving detection and treatment of mental disorders, but rigorous evidence specifically for integrating suicide prevention into primary care remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Primary Care Providers * Health workers with a prescribing license employed in government health facilities in Bagmati Province. * Are between 21-65 years, per government health system criteria. * Participants will be required to have competency in Nepali, be actively engaged in care provision within their health facility Patients: * Patient lives in the study site * Is under the care of a PCP at a facility site. * Patient meets any level of suicide risk based on mhGAP 2.0 criteria. * Patients who have been treated for mental illness before or presently (expected in both groups). * Speaks Nepali. * Levels of Suicide Risk (as defined by mhGAP 2.0) Exclusion Criteria: Primary Care Providers * Healthcare workers without proper government credentials will be excluded. * Health workers who plan to migrate or who do not intend to stay in the study area for at least a year. Patients: * Patient requiring immediate hospitalization * Unable to consent as determined by the diminished capacity tool.
Where it's running
-
Primary care facilities
Dolakhā, Nepal Recruiting
Study contacts
- Principal investigator: Ashley K Hagaman, PhD, MPH — Yale School of Public Health
- Study coordinator: Ashley K Hagaman, PhD, MPH
- Email: ashley.hagaman@yale.edu
- Phone: 2487908954
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Friends and family training for those at risk of suicide
A six-week program tests whether training for caregivers can help them support a loved one at risk of suicide while also taking care of their own mental health.
-
Inhaled DMT for major depressive disorder
This trial tests whether inhaled DMT can quickly ease depressive symptoms and reduce suicide risk in adults with major depressive disorder.
-
Suicide risk and learned suicide ability in people with mood disorders
This project will try to identify which biological, psychological, social, and clinical factors relate to suicide risk and the learned ability for suicide in people aged 16–60 with mood disorders by collecting blood, urine, and questionnaire data.
-
Combining the Youth-Nominated Support Team with CBT for Black adolescents at acute suicide risk
This project will test whether adding a computer-assisted Youth-Nominated Support Team to Cognitive Behavioral Therapy for Suicide Prevention helps Black adolescents (ages 12-17) who come to an urban emergency setting with suicidal thoughts or self-injury.
-
Remote case management to prevent suicide after psychiatric hospital discharge
This project will test whether a 6-month remote program called Pathfinding helps active-duty Army soldiers reduce suicidal behavior after leaving inpatient psychiatric care.
-
Text reminders to help parents keep teens safe after a suicide-related ED visit
This study tests whether sending parents text messages can help them reduce their teen’s access to lethal means and increase safety practices after a suicide-related emergency visit.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.